Patient Stratification Engine
Overview
Classify patients into risk tiers based on clinical complexity, utilization patterns, social determinants, and predicted outcomes using validated risk stratification methodologies. This skill supports population health management, care management resource allocation, and value-based care program design by identifying which patients need which level of intervention.
When to Use
- Building risk-stratified patient panels for care management programs
- Prioritizing high-risk patients for proactive outreach
- Allocating care management resources based on patient acuity
- Supporting ACO/value-based care population segmentation
- Identifying rising-risk patients before they become high-cost
- Designing tiered intervention programs based on risk levels
Required Inputs
| Input |
Description |
Format |
| Patient demographics |
Age, sex, race/ethnicity, insurance, ZIP |
Structured object |
| Clinical profile |
Active diagnoses (ICD-10), medications, labs |
Structured arrays |
| Utilization history |
ED visits, admissions, office visits (12-24 months) |
Structured array with dates |
| Claims/cost data |
Total cost of care, cost by category |
Numeric |
| SDOH indicators |
Housing, food security, transportation, social support |
Structured object |
| Functional status |
ADL/IADL scores, cognitive status if available |
Structured object |
Methodology
Step 1: Clinical Complexity Scoring
Calculate disease burden and clinical complexity:
HCC (Hierarchical Condition Category) Risk Score:
- Map active ICD-10 diagnoses to HCC categories
- Calculate CMS-HCC risk adjustment factor (RAF)
- Benchmark against population average (1.0)
- Higher RAF = higher predicted cost and clinical complexity
Charlson Comorbidity Index (CCI):
- Score comorbidities: MI, CHF, PVD, CVD, dementia, COPD, connective tissue disease, PUD, liver disease, diabetes, hemiplegia, CKD, cancer, AIDS
- Each condition scores 1-6 based on severity
- Total CCI predicts 10-year mortality risk
Elixhauser Comorbidity Measure:
- 31 comorbidity categories beyond Charlson
- Captures conditions like depression, obesity, drug abuse, psychoses
- Better predictor for in-hospital mortality and LOS
Step 2: Utilization Pattern Analysis
Evaluate healthcare utilization intensity:
| Metric |
Low Risk |
Moderate |
High |
Very High |
| ED visits (12 mo) |
0-1 |
2-3 |
4-5 |
6+ |
| Inpatient admits (12 mo) |
0 |
1 |
2-3 |
4+ |
| Specialists seen |
0-2 |
3-4 |
5-7 |
8+ |
| Total cost of care |
Below 50th pctl |
50-75th pctl |
75-90th pctl |
Above 90th pctl |
| Readmissions (30-day) |
None |
1 |
2+ |
Multiple |
Step 3: Social Risk Assessment
Evaluate social determinants that amplify clinical risk:
SDOH Risk Factors (scored 0-2 each):
- Housing instability or homelessness (0=stable, 1=at risk, 2=unstable)
- Food insecurity (0=secure, 1=low security, 2=very low)
- Transportation barriers (0=none, 1=occasional, 2=frequent)
- Social isolation (0=connected, 1=limited, 2=isolated)
- Health literacy (0=adequate, 1=limited, 2=low)
- Financial strain (0=stable, 1=some stress, 2=severe)
Total SDOH score: 0-12 (Low: 0-3, Moderate: 4-7, High: 8-12)
Step 4: Composite Risk Tier Assignment
Combine clinical, utilization, and social scores into a composite tier:
| Risk Tier |
Clinical |
Utilization |
SDOH |
Recommended Intervention Level |
| Tier 1 - Healthy/Low |
Low CCI, few conditions |
Minimal utilization |
Low SDOH risk |
Prevention and wellness |
| Tier 2 - Rising Risk |
Moderate CCI, chronic conditions emerging |
Increasing utilization |
Low-Moderate SDOH |
Disease management, self-management support |
| Tier 3 - High Risk |
High CCI, multiple chronic conditions |
Frequent utilization |
Moderate-High SDOH |
Care management, care coordination |
| Tier 4 - Complex/Very High |
Very high CCI, frailty, functional decline |
Very frequent utilization |
High SDOH |
Intensive care management, multidisciplinary team |
Step 5: Actionable Segmentation
Assign patients to intervention programs based on tier and dominant risk drivers:
Tier-Based Program Mapping:
- Tier 1: Preventive outreach, annual wellness visits, gap closure
- Tier 2: Chronic disease education, medication management, care gap alerts
- Tier 3: Assigned care manager, regular check-ins, transition management
- Tier 4: Intensive care team (RN + SW + pharmacist + CHW), home visits, high-touch coordination
Output Specification
The output includes:
patient_profile: demographics, insurance, pcp assignment
clinical_complexity: hcc_raf_score, charlson_cci, active_conditions_count, medication_count, high_risk_conditions list
utilization_profile: ed_visits_12mo, admissions_12mo, readmissions, specialist_count, total_cost_of_care, cost_percentile
sdoh_assessment: individual factor scores, total_sdoh_score, sdoh_risk_level
composite_stratification: risk_tier (1-4), tier_label, composite_score, dominant_risk_domain, confidence_level
intervention_assignment: program_name, intervention_level, recommended_team_composition, key_focus_areas, engagement_frequency
rising_risk_indicators: flags for patients trending toward higher tier (increasing utilization, new diagnoses, SDOH changes)
Analysis Framework
Impactability Assessment
Not all high-risk patients are equally impactable. Assess:
- Modifiable risk factors present: Can interventions change the trajectory?
- Patient engagement likelihood: History of appointment adherence, responsiveness
- Intervention availability: Are appropriate programs and resources available?
- Cost-effectiveness: Will intervention costs be offset by utilization reduction?
Impactability Score: High (good candidate for intensive program), Medium (moderate intervention), Low (maintain monitoring, fewer modifiable factors)
Trend Analysis
Track tier movement over time:
- Improving: Moving to lower risk tier (intervention success indicator)
- Stable: Remaining in same tier (maintenance mode)
- Worsening: Moving to higher tier (intervention escalation needed)
- Rising risk: Not yet high tier but trending upward (early intervention opportunity)
Examples
Input: 72-year-old male, CHF (EF 35%), DM2 with neuropathy, CKD Stage 3a, depression. On 12 medications. 3 ED visits in 12 months, 2 hospital admissions (1 readmission). Lives alone in rural area. Limited transportation. Income below 200% FPL.
Stratification:
- Clinical: HCC-RAF 2.4 (high), CCI 6 (high), 4 active chronic conditions, polypharmacy
- Utilization: 3 ED, 2 admits, 1 readmission — HIGH
- SDOH: Social isolation (2) + transportation (2) + financial (2) = 6/12 — MODERATE
- Composite: Tier 4 - Complex/Very High
- Dominant driver: Clinical complexity + utilization intensity
- Recommended: Intensive care management team with home health, telemonitoring, community health worker for transportation, pharmacist for medication management
Guidelines
- Stratification is dynamic — reassess at least quarterly or after significant clinical events
- Avoid label bias — risk tiers inform resource allocation, not patient worth
- Include rising-risk identification — intervening before patients become high-risk is most cost-effective
- Validate models against outcomes — regularly calibrate stratification against actual utilization and costs
- Ensure equity — audit stratification for demographic bias and disparities
Validation Checklist
HIPAA Compliance Notes
- Risk stratification data aggregates extensive PHI and requires strict access controls
- Share stratification results only with care team members with a need to know
- De-identify population-level stratification reports for quality improvement
- SDOH data may have additional privacy requirements under state law
- Patient consent should be obtained before enrolling in care management programs based on stratification
- Maintain audit logs for all stratification data access and sharing
1---2name: patient-stratification-engine3description: Risk-stratify patients into actionable tiers using clinical, utilization, and social determinant data with validated risk models. Use when building risk-stratified patient panels, prioritizing care management resources, supporting population health initiatives, or identifying patients for intensive intervention programs.4---56# Patient Stratification Engine78## Overview910Classify patients into risk tiers based on clinical complexity, utilization patterns, social determinants, and predicted outcomes using validated risk stratification methodologies. This skill supports population health management, care management resource allocation, and value-based care program design by identifying which patients need which level of intervention.1112## When to Use1314- Building risk-stratified patient panels for care management programs15- Prioritizing high-risk patients for proactive outreach16- Allocating care management resources based on patient acuity17- Supporting ACO/value-based care population segmentation18- Identifying rising-risk patients before they become high-cost19- Designing tiered intervention programs based on risk levels2021## Required Inputs2223| Input | Description | Format |24|-------|-------------|--------|25| Patient demographics | Age, sex, race/ethnicity, insurance, ZIP | Structured object |26| Clinical profile | Active diagnoses (ICD-10), medications, labs | Structured arrays |27| Utilization history | ED visits, admissions, office visits (12-24 months) | Structured array with dates |28| Claims/cost data | Total cost of care, cost by category | Numeric |29| SDOH indicators | Housing, food security, transportation, social support | Structured object |30| Functional status | ADL/IADL scores, cognitive status if available | Structured object |3132## Methodology3334### Step 1: Clinical Complexity Scoring3536Calculate disease burden and clinical complexity:3738**HCC (Hierarchical Condition Category) Risk Score:**39- Map active ICD-10 diagnoses to HCC categories40- Calculate CMS-HCC risk adjustment factor (RAF)41- Benchmark against population average (1.0)42- Higher RAF = higher predicted cost and clinical complexity4344**Charlson Comorbidity Index (CCI):**45- Score comorbidities: MI, CHF, PVD, CVD, dementia, COPD, connective tissue disease, PUD, liver disease, diabetes, hemiplegia, CKD, cancer, AIDS46- Each condition scores 1-6 based on severity47- Total CCI predicts 10-year mortality risk4849**Elixhauser Comorbidity Measure:**50- 31 comorbidity categories beyond Charlson51- Captures conditions like depression, obesity, drug abuse, psychoses52- Better predictor for in-hospital mortality and LOS5354### Step 2: Utilization Pattern Analysis5556Evaluate healthcare utilization intensity:5758| Metric | Low Risk | Moderate | High | Very High |59|--------|----------|----------|------|-----------|60| ED visits (12 mo) | 0-1 | 2-3 | 4-5 | 6+ |61| Inpatient admits (12 mo) | 0 | 1 | 2-3 | 4+ |62| Specialists seen | 0-2 | 3-4 | 5-7 | 8+ |63| Total cost of care | Below 50th pctl | 50-75th pctl | 75-90th pctl | Above 90th pctl |64| Readmissions (30-day) | None | 1 | 2+ | Multiple |6566### Step 3: Social Risk Assessment6768Evaluate social determinants that amplify clinical risk:6970**SDOH Risk Factors (scored 0-2 each):**71- Housing instability or homelessness (0=stable, 1=at risk, 2=unstable)72- Food insecurity (0=secure, 1=low security, 2=very low)73- Transportation barriers (0=none, 1=occasional, 2=frequent)74- Social isolation (0=connected, 1=limited, 2=isolated)75- Health literacy (0=adequate, 1=limited, 2=low)76- Financial strain (0=stable, 1=some stress, 2=severe)7778Total SDOH score: 0-12 (Low: 0-3, Moderate: 4-7, High: 8-12)7980### Step 4: Composite Risk Tier Assignment8182Combine clinical, utilization, and social scores into a composite tier:8384| Risk Tier | Clinical | Utilization | SDOH | Recommended Intervention Level |85|-----------|----------|-------------|------|-------------------------------|86| Tier 1 - Healthy/Low | Low CCI, few conditions | Minimal utilization | Low SDOH risk | Prevention and wellness |87| Tier 2 - Rising Risk | Moderate CCI, chronic conditions emerging | Increasing utilization | Low-Moderate SDOH | Disease management, self-management support |88| Tier 3 - High Risk | High CCI, multiple chronic conditions | Frequent utilization | Moderate-High SDOH | Care management, care coordination |89| Tier 4 - Complex/Very High | Very high CCI, frailty, functional decline | Very frequent utilization | High SDOH | Intensive care management, multidisciplinary team |9091### Step 5: Actionable Segmentation9293Assign patients to intervention programs based on tier and dominant risk drivers:9495**Tier-Based Program Mapping:**96- Tier 1: Preventive outreach, annual wellness visits, gap closure97- Tier 2: Chronic disease education, medication management, care gap alerts98- Tier 3: Assigned care manager, regular check-ins, transition management99- Tier 4: Intensive care team (RN + SW + pharmacist + CHW), home visits, high-touch coordination100101## Output Specification102103The output includes:104105**patient_profile**: demographics, insurance, pcp assignment106107**clinical_complexity**: hcc_raf_score, charlson_cci, active_conditions_count, medication_count, high_risk_conditions list108109**utilization_profile**: ed_visits_12mo, admissions_12mo, readmissions, specialist_count, total_cost_of_care, cost_percentile110111**sdoh_assessment**: individual factor scores, total_sdoh_score, sdoh_risk_level112113**composite_stratification**: risk_tier (1-4), tier_label, composite_score, dominant_risk_domain, confidence_level114115**intervention_assignment**: program_name, intervention_level, recommended_team_composition, key_focus_areas, engagement_frequency116117**rising_risk_indicators**: flags for patients trending toward higher tier (increasing utilization, new diagnoses, SDOH changes)118119## Analysis Framework120121### Impactability Assessment122123Not all high-risk patients are equally impactable. Assess:1241251. **Modifiable risk factors present**: Can interventions change the trajectory?1262. **Patient engagement likelihood**: History of appointment adherence, responsiveness1273. **Intervention availability**: Are appropriate programs and resources available?1284. **Cost-effectiveness**: Will intervention costs be offset by utilization reduction?129130Impactability Score: High (good candidate for intensive program), Medium (moderate intervention), Low (maintain monitoring, fewer modifiable factors)131132### Trend Analysis133134Track tier movement over time:135- **Improving**: Moving to lower risk tier (intervention success indicator)136- **Stable**: Remaining in same tier (maintenance mode)137- **Worsening**: Moving to higher tier (intervention escalation needed)138- **Rising risk**: Not yet high tier but trending upward (early intervention opportunity)139140## Examples141142**Input**: 72-year-old male, CHF (EF 35%), DM2 with neuropathy, CKD Stage 3a, depression. On 12 medications. 3 ED visits in 12 months, 2 hospital admissions (1 readmission). Lives alone in rural area. Limited transportation. Income below 200% FPL.143144**Stratification**:145- Clinical: HCC-RAF 2.4 (high), CCI 6 (high), 4 active chronic conditions, polypharmacy146- Utilization: 3 ED, 2 admits, 1 readmission — HIGH147- SDOH: Social isolation (2) + transportation (2) + financial (2) = 6/12 — MODERATE148- Composite: **Tier 4 - Complex/Very High**149- Dominant driver: Clinical complexity + utilization intensity150- Recommended: Intensive care management team with home health, telemonitoring, community health worker for transportation, pharmacist for medication management151152## Guidelines1531541. **Stratification is dynamic** — reassess at least quarterly or after significant clinical events1552. **Avoid label bias** — risk tiers inform resource allocation, not patient worth1563. **Include rising-risk identification** — intervening before patients become high-risk is most cost-effective1574. **Validate models against outcomes** — regularly calibrate stratification against actual utilization and costs1585. **Ensure equity** — audit stratification for demographic bias and disparities159160## Validation Checklist161162- [ ] All data inputs are current (within 90 days for clinical, 12 months for utilization)163- [ ] HCC coding is complete and accurate (capture all relevant conditions)164- [ ] SDOH assessment is completed (not defaulted to zero/unknown)165- [ ] Composite tier assignment reflects the dominant risk driver166- [ ] Intervention assignments match available program capacity167- [ ] Rising-risk indicators are flagged for proactive intervention168- [ ] Stratification model is calibrated against actual outcomes169170## HIPAA Compliance Notes171172- Risk stratification data aggregates extensive PHI and requires strict access controls173- Share stratification results only with care team members with a need to know174- De-identify population-level stratification reports for quality improvement175- SDOH data may have additional privacy requirements under state law176- Patient consent should be obtained before enrolling in care management programs based on stratification177- Maintain audit logs for all stratification data access and sharing